Stockreport

IceCure's ProSense® Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer [Yahoo! Finance]

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF Food and Drug Administration's ("FDA") recent marketing authorization of ProSense® in low-risk breast cancer CAESAREA, Israel Nov. 18, 2025 /PRNewswire/ -- IceCure Med [Read more]